APO RESEARCH · REPORT
Artesunate Tablet
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Product & engineering
Understand the product.
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Selected research
Market Structure
Global Artesunate Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Global Artesunate Tablet main players include Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare, etc., totally accounting for about 70%. Central and South America is the largest market, with a share over 75%. As for the types of products, it can be divided into PA 90 Content, PA 95 Content and PA 98 Content. The most common product is Monoaromatic Artesunate and Compound Artesunate. In terms of applications, it is widely used in Hospital, Clinic and Others. The most application is in Hospital, with a share over 67%.
This report provides an overview of the global Artesunate Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Artesunate Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artesunate Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artesunate Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Artesunate Tablet Segment by Company
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
Artesunate Tablet Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Artesunate Tablet Segment by Application
Hospital
Clinic
Others
Artesunate Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artesunate Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artesunate Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artesunate Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artesunate Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Artesunate Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Monoaromatic Artesunate
- Compound Artesunate
Applications
- Hospital
- Clinic
- Others
Companies covered
- Fosun Pharma (Guilin)
- Ipca Laboratories
- Sanofi Aventis
- Ajanta Pharma
- Shin Poong
- Cipla
- Acino
- MCW Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Artesunate Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Artesunate Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Artesunate Tablet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Artesunate Tablet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Artesunate Tablet Market Dynamics
- 2.1 Artesunate Tablet Industry Trends
- 2.2 Artesunate Tablet Industry Drivers
- 2.3 Artesunate Tablet Industry Opportunities and Challenges
- 2.4 Artesunate Tablet Industry Restraints
3 Artesunate Tablet Market by Manufacturers
- 3.1 Global Artesunate Tablet Revenue by Manufacturers (2021-2026)
- 3.2 Global Artesunate Tablet Sales by Manufacturers (2021-2026)
- 3.3 Global Artesunate Tablet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Artesunate Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artesunate Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artesunate Tablet Manufacturers, Product Type & Application
- 3.7 Global Artesunate Tablet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artesunate Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artesunate Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Artesunate Tablet Tier 1, Tier 2, and Tier 3
4 Artesunate Tablet Market by Type
- 4.1 Artesunate Tablet Type Introduction
- 4.1.1 Monoaromatic Artesunate
- 4.1.2 Compound Artesunate
- 4.2 Global Artesunate Tablet Sales by Type
- 4.2.1 Global Artesunate Tablet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artesunate Tablet Sales by Type (2021-2032)
- 4.2.3 Global Artesunate Tablet Sales Market Share by Type (2021-2032)
- 4.3 Global Artesunate Tablet Revenue by Type
- 4.3.1 Global Artesunate Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artesunate Tablet Revenue by Type (2021-2032)
- 4.3.3 Global Artesunate Tablet Revenue Market Share by Type (2021-2032)
5 Artesunate Tablet Market by Application
- 5.1 Artesunate Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Artesunate Tablet Sales by Application
- 5.2.1 Global Artesunate Tablet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artesunate Tablet Sales by Application (2021-2032)
- 5.2.3 Global Artesunate Tablet Sales Market Share by Application (2021-2032)
- 5.3 Global Artesunate Tablet Revenue by Application
- 5.3.1 Global Artesunate Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artesunate Tablet Revenue by Application (2021-2032)
- 5.3.3 Global Artesunate Tablet Revenue Market Share by Application (2021-2032)
6 Global Artesunate Tablet Sales by Region
- 6.1 Global Artesunate Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artesunate Tablet Sales by Region (2021-2032)
- 6.2.1 Global Artesunate Tablet Sales by Region (2021-2026)
- 6.2.2 Global Artesunate Tablet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artesunate Tablet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artesunate Tablet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artesunate Tablet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Artesunate Tablet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Artesunate Tablet Revenue by Region
- 7.1 Global Artesunate Tablet Revenue by Region
- 7.1.1 Global Artesunate Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Artesunate Tablet Revenue by Region (2021-2026)
- 7.1.3 Global Artesunate Tablet Revenue by Region (2027-2032)
- 7.1.4 Global Artesunate Tablet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Artesunate Tablet Revenue (2021-2032)
- 7.2.2 North America Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Artesunate Tablet Revenue (2021-2032)
- 7.3.2 Europe Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Artesunate Tablet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Artesunate Tablet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Fosun Pharma (Guilin)
- 8.1.1 Fosun Pharma (Guilin) Company Information
- 8.1.2 Fosun Pharma (Guilin) Business Overview
- 8.1.3 Fosun Pharma (Guilin) Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Fosun Pharma (Guilin) Artesunate Tablet Product Portfolio
- 8.1.5 Fosun Pharma (Guilin) Recent Developments
- 8.2 Ipca Laboratories
- 8.2.1 Ipca Laboratories Company Information
- 8.2.2 Ipca Laboratories Business Overview
- 8.2.3 Ipca Laboratories Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Ipca Laboratories Artesunate Tablet Product Portfolio
- 8.2.5 Ipca Laboratories Recent Developments
- 8.3 Sanofi Aventis
- 8.3.1 Sanofi Aventis Company Information
- 8.3.2 Sanofi Aventis Business Overview
- 8.3.3 Sanofi Aventis Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sanofi Aventis Artesunate Tablet Product Portfolio
- 8.3.5 Sanofi Aventis Recent Developments
- 8.4 Ajanta Pharma
- 8.4.1 Ajanta Pharma Company Information
- 8.4.2 Ajanta Pharma Business Overview
- 8.4.3 Ajanta Pharma Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Ajanta Pharma Artesunate Tablet Product Portfolio
- 8.4.5 Ajanta Pharma Recent Developments
- 8.5 Shin Poong
- 8.5.1 Shin Poong Company Information
- 8.5.2 Shin Poong Business Overview
- 8.5.3 Shin Poong Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shin Poong Artesunate Tablet Product Portfolio
- 8.5.5 Shin Poong Recent Developments
- 8.6 Cipla
- 8.6.1 Cipla Company Information
- 8.6.2 Cipla Business Overview
- 8.6.3 Cipla Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cipla Artesunate Tablet Product Portfolio
- 8.6.5 Cipla Recent Developments
- 8.7 Acino
- 8.7.1 Acino Company Information
- 8.7.2 Acino Business Overview
- 8.7.3 Acino Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Acino Artesunate Tablet Product Portfolio
- 8.7.5 Acino Recent Developments
- 8.8 MCW Healthcare
- 8.8.1 MCW Healthcare Company Information
- 8.8.2 MCW Healthcare Business Overview
- 8.8.3 MCW Healthcare Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 MCW Healthcare Artesunate Tablet Product Portfolio
- 8.8.5 MCW Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Artesunate Tablet Value Chain Analysis
- 9.1.1 Artesunate Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artesunate Tablet Production Mode & Process
- 9.2 Artesunate Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artesunate Tablet Distributors
- 9.2.3 Artesunate Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst